Posted in | News

CERATECH’s KEMROK Cement Concrete Demonstrates Superior Acid Resistance

CERATECH has revealed the test results that proved its KEMROK cement can bear acid attack. The innovative cement significantly reduces product downtime and maintenance expenditures. Its superior corrosion resistance increases product lifetime, which in turn yields high return on investment.

KEMROK cement demonstrates better durability to Portland cement in acid resistance tests

In tests conducted as per the guidelines of ASTM C-267, technicians immersed samples of concrete, one made with KEMROK cement and another one with Portland cement, in different acid solutions, including hydrochloric, acetic, phosphoric and sulfuric acid.

After exposure to 93% sulfuric acid for 84 days, the concrete made with KEMROK cement had lost just above 1% of its mass and 5% of its compressive strength, while the loss on Portland cement-based concrete’s mass was more than 4% and strength was 18%. Moreover, the Portland cement concrete had constantly deteriorated, while deterioration to KEMROK cement concrete almost ended after a month.

As concrete is continually in contact with sulfuric acid in their processing facilities, the test on sulfuric acid durability is critical for petrochemical manufacturers. KEMROK cement concrete had demonstrated superior durability than the Portland cement concrete in exposure to other acids.

As all cement products of CERATECH, including KEMROK are produced from 95% recycled materials and 5% renewable materials in a nearly carbon-zero process, they are ideal for companies involved in green building practices. The Executive Vice President at CERATECH, Mark Wasilko stated that the company offers cement products with better sustainability, durability and they are readily available in the market.

Source: http://www.ceratechinc.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). CERATECH’s KEMROK Cement Concrete Demonstrates Superior Acid Resistance. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=14538.

  • MLA

    Scanlon, Joel. "CERATECH’s KEMROK Cement Concrete Demonstrates Superior Acid Resistance". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=14538>.

  • Chicago

    Scanlon, Joel. "CERATECH’s KEMROK Cement Concrete Demonstrates Superior Acid Resistance". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14538. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. CERATECH’s KEMROK Cement Concrete Demonstrates Superior Acid Resistance. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=14538.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.